Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $723
Argenx Analyst Ratings
Wells Fargo Maintains Overweight on Argenx, Raises Price Target to $723
Argenx Se (ARGX) Gets a Hold From UBS
Leerink Partners Maintains Argenx SE(ARGX.US) With Buy Rating, Announces Target Price $635
Stifel Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $772
Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $681
Citi Reaffirms Their Buy Rating on Argenx Se (ARGX)
Argenx Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $706
Oppenheimer Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $675
Jefferies Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $689
Jefferies Sticks to Their Buy Rating for Argenx Se (ARGX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $606 to $770
Argenx Analyst Ratings
Argenx Se's Promising Clinical Advancements and Positive ALKIVIA Study Results Underpin Buy Rating
Morgan Stanley Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $675
Truist Financial Maintains Argenx SE(ARGX.US) With Buy Rating
Morgan Stanley Raises Price Target on Argenx to $675 From $580, Keeps Overweight Rating